CSIMarket
 


Fonar Corporation  (FONR)
Other Ticker:  
 
 

FONR's Revenue Growth by Quarter and Year

Fonar's Revenue results by quarter and year




FONR Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 25.78 24.81 16.70
III Quarter March - 25.42 24.57 25.92
II Quarter December 25.39 24.26 24.48 23.81
I Quarter September 25.84 23.19 23.73 23.50
FY   51.23 98.65 97.59 89.93



FONR Revenue second quarter 2024 Y/Y Growth Comment
Fonar Corporation reported Revenue growth of 4.64% year on year in the second quarter 2024, to $ 25.39 millions, this is lower than Fonar Corporation's recent average Revenue growth of 5.41%.

Looking into second quarter 2024 results within Medical Equipment & Supplies industry 65 other companies have achieved higher Revenue growth. While Fonar Corporation' s Revenue increase of 4.64% ranks overall at the positon no. 1145 in the second quarter 2024.




FONR Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - 3.91 % 48.56 % 37.45 %
III Quarter March - 3.46 % -5.21 % 5.67 %
II Quarter December 4.64 % -0.9 % 2.81 % -2.46 %
I Quarter September 11.43 % -2.28 % 0.98 % -4.51 %
FY   - 1.09 % 8.52 % 4.94 %

Financial Statements
Fonar's second quarter 2024 Revenue $ 25.39 millions FONR's Income Statement
Fonar's second quarter 2023 Revenue $ 24.26 millions Quarterly FONR's Income Statement
New: More FONR's historic Revenue Growth >>


FONR Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - 1.42 % 0.98 % -35.57 %
III Quarter March - 4.78 % 0.37 % 8.86 %
II Quarter December -1.76 % 4.61 % 3.16 % 1.32 %
I Quarter September 0.23 % -6.53 % 42.1 % 93.42 %
FY (Year on Year)   - 1.09 % 8.52 % 4.94 %




Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #66
Healthcare Sector #193
Overall #1145

Revenue Y/Y Growth Statistics
High Average Low
83.18 % 5.41 % -38.98 %
(Dec 31 2013)   (Jun 30 2013)
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #66
Healthcare Sector #193
Overall #1145
Revenue Y/Y Growth Statistics
High Average Low
83.18 % 5.41 % -38.98 %
(Dec 31 2013)   (Jun 30 2013)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Fonar's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
93.49 % 0.77 % -100 %
(Sep 30 2020)  


FONR's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2024 Fonar Corporation realized decrease in Revenue from the first quarter by -1.76% to $ 25.39 millions, from $ 25.84 millions declared in the previous quarter.

Some cyclical circumstance have not salvage the II. Quarter for the Fonar Corporation, Kimberly Thompson, Medical Equipment & Supplies industry contributor wrote.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Fonar's Revenue growth quarter on quarter, overall rank is 502.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #63
Overall #502
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #21
Healthcare Sector #63
Overall #502
Revenue Q/Q Growth Statistics
High Average Low
93.49 % 0.77 % -100 %
(Sep 30 2020)  


FONR's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2024 Fonar Corporation reported decrease in Revenue from the previous quarter by -1.76% to $ 25.39 millions, from $ 25.84 millions released a quarter before.

Although seasonal influence commonly fuel II. Quarter 2024 Revenue, that plainly could not be substantial to recover FONR's achievement, Kimberly Thompson, Medical Equipment & Supplies industry contributor said and wrote that average quarter on quarter Revenue growth is at 0.77% for the Medical Equipment & Supplies's company.

Within Medical Equipment & Supplies industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Fonar's Revenue growth quarter on quarter, overall rank is 502.


Fonar's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 102.42 $ 101.29 $ 98.65 $ 97.68 $ 96.83
Y / Y Revenue Growth (TTM) 5.78 % 4.37 % 1.08 % 9.17 % 6.61 %
Year on Year Revenue Growth Overall Ranking # 336 # 1330 # 1714 # 2198 # 1346
Seqeuential Revenue Change (TTM) 1.12 % 2.68 % 0.99 % 0.88 % -0.23 %
Seq. Revenue Growth (TTM) Overall Ranking # 487 # 2000 # 1690 # 2612 # 2756




Cumulative Revenue growth Comment
Although Fonar's Annual Revenue growth year on year were below company's average 7.36% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.78% year on year, from 4.37% in Sep 30 2023.

In the Healthcare sector 36 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 336, from total ranking in previous quarter at 1330.

Revenue TTM Q/Q Growth Statistics
High Average Low
93.77 %
7.36 %
-8.29 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 21
Healthcare Sector # 37
Overall # 336

Revenue TTM Y/Y Growth Statistics
High Average Low
93.77 %
7.36 %
-8.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 55
S&P 500 # 487
Cumulative Revenue growth Comment
Although Fonar's Annual Revenue growth year on year were below company's average 7.36% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 5.78% year on year, from 4.37% in Sep 30 2023.

In the Healthcare sector 36 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 336, from total ranking in previous quarter at 1330.

Revenue TTM Q/Q Growth Statistics
High Average Low
93.77 %
7.36 %
-8.29 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 21
Healthcare Sector # 37
Overall # 336

Revenue TTM Y/Y Growth Statistics
High Average Low
93.77 %
7.36 %
-8.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 55
S&P 500 # 487




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
FONR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for FONR's Competitors
Revenue Growth for Fonar's Suppliers
Revenue Growth for FONR's Customers

You may also want to know
FONR's Annual Growth Rates FONR's Profitability Ratios FONR's Asset Turnover Ratio FONR's Dividend Growth
FONR's Roe FONR's Valuation Ratios FONR's Financial Strength Ratios FONR's Dividend Payout Ratio
FONR's Roa FONR's Inventory Turnover Ratio FONR's Growth Rates FONR's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
National Vision Holdings Inc 7.99%$ 7.991 millions
Davita Inc 7.85%$ 7.846 millions
Tenet Healthcare Corp7.80%$ 7.796 millions
Nature s Sunshine Products inc 7.67%$ 7.671 millions
Organon and Co 7.61%$ 7.609 millions
Exagen Inc 7.23%$ 7.229 millions
Chemed Corporation7.18%$ 7.182 millions
Sonoma Pharmaceuticals Inc 6.59%$ 6.590 millions
Align Technology inc 6.16%$ 6.158 millions
Dr Reddy s Laboratories Limited5.87%$ 5.874 millions
Elanco Animal Health Inc5.50%$ 5.505 millions
Royalty Pharma Plc5.36%$ 5.359 millions
Zai Lab Limited5.16%$ 5.160 millions
Ocular Therapeutix Inc 5.16%$ 5.158 millions
Tactile Systems Technology Inc 5.05%$ 5.046 millions
Select Medical Holdings Corp4.89%$ 4.894 millions
Icon Plc4.89%$ 4.893 millions
Fonar Corporation4.66%$ 4.659 millions
Novocure Limited4.17%$ 4.170 millions
Owens and Minor inc4.13%$ 4.127 millions
Surgery Partners Inc 4.00%$ 4.002 millions
Teladoc Health Inc 3.58%$ 3.578 millions
Iqvia Holdings Inc 3.45%$ 3.450 millions
Castle Biosciences Inc 3.39%$ 3.387 millions
Astrazeneca Plc3.29%$ 3.292 millions
West Pharmaceutical Services Inc 3.22%$ 3.217 millions
Becton Dickinson And Company2.62%$ 2.617 millions
Cumberland Pharmaceuticals Inc2.51%$ 2.514 millions
Prestige Consumer Healthcare Inc 2.33%$ 2.328 millions
Sanofi2.32%$ 2.324 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com